Although the MSLN protein is expressed at low levels in HMs, it is overexpressed in asbestos-exposed subjects (23, 24) and aberrantly expressed in several solid tumors, including gastric, lung, pancreatic, and ovarian cancers as well as in mesothelioma (25). Here, MSLN is linked to ovarian carcinoma.